HK Stock MarketDetailed Quotes

00570 TRAD CHI MED

Watchlist
  • 2.320
  • +0.010+0.43%
Market Closed Dec 27 16:08 CST
11.68BMarket Cap11.60P/E (TTM)

TRAD CHI MED Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-9.86%8.39B
26.69%18.12B
57.37%9.3B
-24.92%14.3B
-27.46%5.91B
28.68%19.05B
22.45%8.15B
3.39%14.81B
-4.06%6.66B
27.20%14.32B
Operating income
-9.86%8.39B
26.69%18.12B
57.37%9.3B
-24.92%14.3B
-27.46%5.91B
28.68%19.05B
22.45%8.15B
3.39%14.81B
-4.06%6.66B
27.20%14.32B
Cost of sales
4.86%-4.32B
-24.51%-8.85B
-53.56%-4.54B
1.63%-7.11B
5.94%-2.96B
-27.17%-7.22B
-19.26%-3.15B
1.13%-5.68B
4.05%-2.64B
-13.42%-5.75B
Operating expenses
4.86%-4.32B
-24.51%-8.85B
-53.56%-4.54B
1.63%-7.11B
5.94%-2.96B
-27.17%-7.22B
-19.26%-3.15B
1.13%-5.68B
4.05%-2.64B
-13.42%-5.75B
Gross profit
-14.64%4.06B
28.84%9.27B
61.19%4.76B
-39.15%7.2B
-41.00%2.95B
29.62%11.83B
24.54%5B
6.42%9.13B
-4.07%4.02B
38.46%8.58B
Selling expenses
13.63%-2.75B
-39.08%-6.4B
-85.61%-3.19B
39.28%-4.6B
43.58%-1.72B
-35.71%-7.58B
-24.58%-3.04B
-9.35%-5.59B
0.43%-2.44B
-49.51%-5.11B
Administrative expenses
-10.20%-512.15M
-10.47%-1.04B
-15.72%-464.75M
3.08%-944.4M
-5.77%-401.61M
-37.77%-974.45M
-13.79%-379.7M
-3.07%-707.28M
-10.10%-333.68M
-24.24%-686.19M
Research and development expenses
14.57%-267.93M
-12.06%-685.63M
1.23%-313.61M
11.90%-611.83M
-7.75%-317.53M
-26.15%-694.44M
-20.13%-294.7M
-18.64%-550.47M
-17.38%-245.32M
-33.89%-464M
Impairment and provision
-232.37%-158.77M
7.02%-9.37M
-29.33%-47.77M
27.42%-10.07M
20.19%-36.94M
74.17%-13.88M
-39.65%-46.28M
-198.32%-53.73M
36.19%-33.14M
-119.87%-18.01M
-Other impairment is provision
-232.37%-158.77M
7.02%-9.37M
-29.33%-47.77M
27.42%-10.07M
20.19%-36.94M
74.17%-13.88M
-39.65%-46.28M
-198.32%-53.73M
36.19%-33.14M
-119.87%-18.01M
Special items of operating profit
-78.55%14.83M
712.16%294.3M
-24.19%69.13M
-80.79%36.24M
18.56%91.19M
-28.22%188.63M
-47.42%76.91M
61.93%262.77M
74.22%146.27M
-13.61%162.28M
Operating profit
-52.76%384.58M
34.11%1.43B
42.82%814.05M
-61.34%1.06B
-56.68%569.97M
10.54%2.75B
18.73%1.32B
1.22%2.49B
-11.61%1.11B
14.13%2.46B
Financing cost
20.07%-84.27M
9.81%-199.05M
-6.97%-105.44M
0.60%-220.7M
10.34%-98.57M
9.25%-222.03M
2.63%-109.93M
18.73%-244.67M
-1.25%-112.89M
-2.99%-301.05M
Share of profits of associates
51.34%-874K
-6.32%-3.7M
-9.51%-1.8M
67.63%-3.48M
79.00%-1.64M
32.29%-10.75M
-60.66%-7.81M
-214.27%-15.87M
-194.01%-4.86M
28.13%-5.05M
Earning before tax
-57.64%299.43M
45.76%1.22B
50.46%706.81M
-66.67%840.11M
-60.78%469.77M
13.01%2.52B
20.96%1.2B
3.50%2.23B
-13.16%990.37M
16.05%2.15B
Tax
5.08%-85.29M
243.97%171.54M
-86.30%-89.85M
69.98%-119.14M
74.78%-48.23M
-7.42%-396.86M
-19.40%-191.24M
3.11%-369.45M
13.90%-160.17M
-31.64%-381.32M
After-tax profit from continuing operations
-65.29%214.14M
93.64%1.4B
46.36%616.96M
-66.05%720.97M
-58.13%421.54M
14.12%2.12B
21.26%1.01B
4.93%1.86B
-13.02%830.2M
13.16%1.77B
Earning after tax
-65.29%214.14M
93.64%1.4B
46.36%616.96M
-66.05%720.97M
-58.13%421.54M
14.12%2.12B
21.26%1.01B
4.93%1.86B
-13.02%830.2M
13.16%1.77B
Minority profit
-91.72%3.16M
354.75%110.87M
380.91%38.22M
-122.84%-43.52M
-89.66%7.95M
-3.46%190.57M
-21.72%76.85M
6.59%197.39M
3.00%98.18M
44.66%185.18M
Profit attributable to shareholders
-63.55%210.98M
68.11%1.29B
39.93%578.74M
-60.45%764.49M
-55.52%413.59M
16.21%1.93B
27.02%929.83M
4.73%1.66B
-14.79%732.02M
10.36%1.59B
Basic earnings per share
-63.53%0.0419
68.12%0.2552
39.95%0.1149
-60.45%0.1518
-55.53%0.0821
16.20%0.3838
26.96%0.1846
4.72%0.3303
-14.77%0.1454
5.70%0.3154
Diluted earnings per share
-63.53%0.0419
68.12%0.2552
39.95%0.1149
-60.45%0.1518
-55.53%0.0821
16.20%0.3838
26.96%0.1846
0.3303
0.1454
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -9.86%8.39B26.69%18.12B57.37%9.3B-24.92%14.3B-27.46%5.91B28.68%19.05B22.45%8.15B3.39%14.81B-4.06%6.66B27.20%14.32B
Operating income -9.86%8.39B26.69%18.12B57.37%9.3B-24.92%14.3B-27.46%5.91B28.68%19.05B22.45%8.15B3.39%14.81B-4.06%6.66B27.20%14.32B
Cost of sales 4.86%-4.32B-24.51%-8.85B-53.56%-4.54B1.63%-7.11B5.94%-2.96B-27.17%-7.22B-19.26%-3.15B1.13%-5.68B4.05%-2.64B-13.42%-5.75B
Operating expenses 4.86%-4.32B-24.51%-8.85B-53.56%-4.54B1.63%-7.11B5.94%-2.96B-27.17%-7.22B-19.26%-3.15B1.13%-5.68B4.05%-2.64B-13.42%-5.75B
Gross profit -14.64%4.06B28.84%9.27B61.19%4.76B-39.15%7.2B-41.00%2.95B29.62%11.83B24.54%5B6.42%9.13B-4.07%4.02B38.46%8.58B
Selling expenses 13.63%-2.75B-39.08%-6.4B-85.61%-3.19B39.28%-4.6B43.58%-1.72B-35.71%-7.58B-24.58%-3.04B-9.35%-5.59B0.43%-2.44B-49.51%-5.11B
Administrative expenses -10.20%-512.15M-10.47%-1.04B-15.72%-464.75M3.08%-944.4M-5.77%-401.61M-37.77%-974.45M-13.79%-379.7M-3.07%-707.28M-10.10%-333.68M-24.24%-686.19M
Research and development expenses 14.57%-267.93M-12.06%-685.63M1.23%-313.61M11.90%-611.83M-7.75%-317.53M-26.15%-694.44M-20.13%-294.7M-18.64%-550.47M-17.38%-245.32M-33.89%-464M
Impairment and provision -232.37%-158.77M7.02%-9.37M-29.33%-47.77M27.42%-10.07M20.19%-36.94M74.17%-13.88M-39.65%-46.28M-198.32%-53.73M36.19%-33.14M-119.87%-18.01M
-Other impairment is provision -232.37%-158.77M7.02%-9.37M-29.33%-47.77M27.42%-10.07M20.19%-36.94M74.17%-13.88M-39.65%-46.28M-198.32%-53.73M36.19%-33.14M-119.87%-18.01M
Special items of operating profit -78.55%14.83M712.16%294.3M-24.19%69.13M-80.79%36.24M18.56%91.19M-28.22%188.63M-47.42%76.91M61.93%262.77M74.22%146.27M-13.61%162.28M
Operating profit -52.76%384.58M34.11%1.43B42.82%814.05M-61.34%1.06B-56.68%569.97M10.54%2.75B18.73%1.32B1.22%2.49B-11.61%1.11B14.13%2.46B
Financing cost 20.07%-84.27M9.81%-199.05M-6.97%-105.44M0.60%-220.7M10.34%-98.57M9.25%-222.03M2.63%-109.93M18.73%-244.67M-1.25%-112.89M-2.99%-301.05M
Share of profits of associates 51.34%-874K-6.32%-3.7M-9.51%-1.8M67.63%-3.48M79.00%-1.64M32.29%-10.75M-60.66%-7.81M-214.27%-15.87M-194.01%-4.86M28.13%-5.05M
Earning before tax -57.64%299.43M45.76%1.22B50.46%706.81M-66.67%840.11M-60.78%469.77M13.01%2.52B20.96%1.2B3.50%2.23B-13.16%990.37M16.05%2.15B
Tax 5.08%-85.29M243.97%171.54M-86.30%-89.85M69.98%-119.14M74.78%-48.23M-7.42%-396.86M-19.40%-191.24M3.11%-369.45M13.90%-160.17M-31.64%-381.32M
After-tax profit from continuing operations -65.29%214.14M93.64%1.4B46.36%616.96M-66.05%720.97M-58.13%421.54M14.12%2.12B21.26%1.01B4.93%1.86B-13.02%830.2M13.16%1.77B
Earning after tax -65.29%214.14M93.64%1.4B46.36%616.96M-66.05%720.97M-58.13%421.54M14.12%2.12B21.26%1.01B4.93%1.86B-13.02%830.2M13.16%1.77B
Minority profit -91.72%3.16M354.75%110.87M380.91%38.22M-122.84%-43.52M-89.66%7.95M-3.46%190.57M-21.72%76.85M6.59%197.39M3.00%98.18M44.66%185.18M
Profit attributable to shareholders -63.55%210.98M68.11%1.29B39.93%578.74M-60.45%764.49M-55.52%413.59M16.21%1.93B27.02%929.83M4.73%1.66B-14.79%732.02M10.36%1.59B
Basic earnings per share -63.53%0.041968.12%0.255239.95%0.1149-60.45%0.1518-55.53%0.082116.20%0.383826.96%0.18464.72%0.3303-14.77%0.14545.70%0.3154
Diluted earnings per share -63.53%0.041968.12%0.255239.95%0.1149-60.45%0.1518-55.53%0.082116.20%0.383826.96%0.18460.33030.1454
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Deloitte Guan Huang Chen Fang Certified Public Accountants--Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks
HK Dividend Stocks HK Dividend Stocks

Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.